168 related articles for article (PubMed ID: 1668284)
1. Immunodeficiency in ESRD-patients is linked to altered IL-2 receptor density on T cell subsets.
Stachowski J; Pollok M; Burrichter H; Baldamus CA
J Clin Lab Immunol; 1991 Apr; 34(4):171-7. PubMed ID: 1668284
[TBL] [Abstract][Full Text] [Related]
2. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
[TBL] [Abstract][Full Text] [Related]
3. T-deficient transmembrane signaling in CD4+ T cells of retroviral-induced immune-deficient mice.
Fitzpatrick EA; Bryson JS; Rhoads C; Kaplan AM; Cohen DA
J Immunol; 1992 Jun; 148(11):3377-84. PubMed ID: 1350288
[TBL] [Abstract][Full Text] [Related]
4. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
de Waal Malefyt R; Yssel H; de Vries JE
J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
[TBL] [Abstract][Full Text] [Related]
5. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes.
Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB
J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264
[TBL] [Abstract][Full Text] [Related]
6. Activation of the interleukin 2 pathway precedes CD3-T cell receptor expression in thymic development. Differential growth requirements of early and mature intrathymic subpopulations.
Toribio ML; De la Hera A; Marcos MA; Márquez C; Martínez C
Eur J Immunol; 1989 Jan; 19(1):9-15. PubMed ID: 2522051
[TBL] [Abstract][Full Text] [Related]
7. Stimulation via the CD3 and CD28 molecules induces responsiveness to IL-4 in CD4+CD29+CD45R- memory T lymphocytes.
Damle NK; Doyle LV
J Immunol; 1989 Sep; 143(6):1761-7. PubMed ID: 2570801
[TBL] [Abstract][Full Text] [Related]
8. IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells.
Martinez OM; Gibbons RS; Garovoy MR; Aronson FR
J Immunol; 1990 Mar; 144(6):2211-5. PubMed ID: 1968925
[TBL] [Abstract][Full Text] [Related]
9. Expression and release of IL-2 receptor and production of IL-2 by activated T lymphocyte subsets.
Shahabuddin S
J Clin Lab Immunol; 1991 Sep; 36(1):27-32. PubMed ID: 1668858
[TBL] [Abstract][Full Text] [Related]
10. Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes.
Sztein MB; Cuna WR; Kierszenbaum F
J Immunol; 1990 May; 144(9):3558-62. PubMed ID: 2139458
[TBL] [Abstract][Full Text] [Related]
11. Preferential expression of IL-2 receptor subunits on memory populations within CD4+ and CD8+ T cells.
Taga K; Kasahara Y; Yachie A; Miyawaki T; Taniguchi N
Immunology; 1991 Jan; 72(1):15-9. PubMed ID: 1900055
[TBL] [Abstract][Full Text] [Related]
12. Different mechanisms of activation of proliferating CD3+ cells in patients with lymphoproliferative disease of granular lymphocytes.
Zambello R; Cassatella MA; Trentin L; Bulian P; Siviero F; Feruglio C; Agostini C; Vespignani M; Chisesi T; Pizzolo G
Leukemia; 1991 Nov; 5(11):942-50. PubMed ID: 1835747
[TBL] [Abstract][Full Text] [Related]
13. Isolated peripheral T cells from GvHR recipients exhibit defective IL-2R expression, IL-2 production, and proliferation in response to activation stimuli.
Levy RB; Jones M; Cray C
J Immunol; 1990 Dec; 145(12):3998-4005. PubMed ID: 1979582
[TBL] [Abstract][Full Text] [Related]
14. Differential in vitro activation of CD8-CD4+ and CD4-CD8+ T lymphocytes by combinations of anti-CD2 and anti-CD3 antibodies.
Yang SY; Rhee S; Welte K; Dupont B
J Immunol; 1988 Apr; 140(7):2115-20. PubMed ID: 3258328
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of murine T cell subsets with anti-CD3 antibody. Age-related defects in the expression of early activation molecules.
Ernst DN; Weigle WO; McQuitty DN; Rothermel AL; Hobbs MV
J Immunol; 1989 Mar; 142(5):1413-21. PubMed ID: 2521878
[TBL] [Abstract][Full Text] [Related]
16. Defective clonogenic potential of CD8+ T lymphocytes in patients with AIDS. Expansion in vivo of a nonclonogenic CD3+CD8+DR+CD25- T cell population.
Pantaleo G; Koenig S; Baseler M; Lane HC; Fauci AS
J Immunol; 1990 Mar; 144(5):1696-704. PubMed ID: 2137842
[TBL] [Abstract][Full Text] [Related]
17. Does uremic environment down-regulate T cell activation via TCR/CD3 antigen receptor complex?
Stachowski J; Pollok M; Burrichter H; Spithaler C; Baldamus CA
J Clin Lab Immunol; 1991 Sep; 36(1):15-21. PubMed ID: 1688213
[TBL] [Abstract][Full Text] [Related]
18. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
Hirsch R; Archibald J; Gress RE
J Immunol; 1991 Oct; 147(7):2088-93. PubMed ID: 1833451
[TBL] [Abstract][Full Text] [Related]
19. Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines.
Pimentel-Muiños FX; Muñoz-Fernández MA; Fresno M
J Immunol; 1994 Jun; 152(12):5714-22. PubMed ID: 8207202
[TBL] [Abstract][Full Text] [Related]
20. Anti-T12, an anti-CD6 monoclonal antibody, can activate human T lymphocytes.
Gangemi RM; Swack JA; Gaviria DM; Romain PL
J Immunol; 1989 Oct; 143(8):2439-47. PubMed ID: 2794503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
